- Home
- ASB vs CRSP Comparison
ASB vs CRSP Comparison
Compare ASB & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASB
- CRSP
- Stock Information
- Founded
- ASB 1861
- CRSP 2013
- Country
- ASB United States
- CRSP Switzerland
- Employees
- ASB N/A
- CRSP N/A
- Industry
- ASB Major Banks
- CRSP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASB Finance
- CRSP Health Care
- Exchange
- ASB Nasdaq
- CRSP Nasdaq
- Market Cap
- ASB 3.4B
- CRSP 3.4B
- IPO Year
- ASB N/A
- CRSP 2016
- Fundamental
- Price
- ASB $22.41
- CRSP $37.40
- Analyst Decision
- ASB Hold
- CRSP Buy
- Analyst Count
- ASB 10
- CRSP 19
- Target Price
- ASB $26.30
- CRSP $74.35
- AVG Volume (30 Days)
- ASB 2.1M
- CRSP 2.3M
- Earning Date
- ASB 04-24-2025
- CRSP 05-12-2025
- Dividend Yield
- ASB 4.09%
- CRSP N/A
- EPS Growth
- ASB N/A
- CRSP N/A
- EPS
- ASB 0.83
- CRSP N/A
- Revenue
- ASB $985,729,000.00
- CRSP $37,314,000.00
- Revenue This Year
- ASB $54.17
- CRSP $51.35
- Revenue Next Year
- ASB $5.51
- CRSP $282.16
- P/E Ratio
- ASB $27.21
- CRSP N/A
- Revenue Growth
- ASB N/A
- CRSP N/A
- 52 Week Low
- ASB $18.32
- CRSP $30.04
- 52 Week High
- ASB $28.18
- CRSP $67.88
- Technical
- Relative Strength Index (RSI)
- ASB 59.21
- CRSP 47.39
- Support Level
- ASB $19.62
- CRSP $36.66
- Resistance Level
- ASB $22.97
- CRSP $39.40
- Average True Range (ATR)
- ASB 0.91
- CRSP 2.12
- MACD
- ASB 0.42
- CRSP 0.38
- Stochastic Oscillator
- ASB 87.96
- CRSP 67.38
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About CRSP CRISPR Therapeutics AG
Crispr Therapeutics AG is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.